Antipsychotics or Mood Stabilizers in Bipolar Disorder: Towards Evidence-Based Personalised Medicine

被引：0
作者：
Tournier, Marie [1 ,2 ]
机构：
[1] Univ Bordeaux, INSERM, Bordeaux Populat Hlth Res Ctr, U1219, Bordeaux, France
[2] Hosp Charles Perrens, Bordeaux, France
来源：
ACTA PSYCHIATRICA SCANDINAVICA | 2025年 / 151卷 / 02期
关键词：
bipolar disorder; pharmacoepidemiology; prevention; THERAPY;
D O I：
10.1111/acps.13780
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：107 / 108
页数：2
相关论文
共 12 条
[11]   Long-term efficacy of quetiapine in combination with lithium or divalproex on mixed symptoms in bipolar I disorder [J].
Vieta, Eduard ;
Suppes, Trisha ;
Ekholm, Birgit ;
Udd, Mattias ;
Gustafsson, Urban .
JOURNAL OF AFFECTIVE DISORDERS, 2012, 142 (1-3) :36-44
[12]   Optimal duration of risperidone or olanzapine adjunctive therapy to mood stabilizer following remission of a manic episode: A CANMAT randomized double-blind trial [J].
Yatham, L. N. ;
Beaulieu, S. ;
Schaffer, A. ;
Kauer-Sant'Anna, M. ;
Kapczinski, F. ;
Lafer, B. ;
Sharma, V. ;
Parikh, S. V. ;
Daigneault, A. ;
Qian, H. ;
Bond, D. J. ;
Silverstone, P. H. ;
Walji, N. ;
Milev, R. ;
Baruch, P. ;
da Cunha, A. ;
Quevedo, J. ;
Dias, R. ;
Kunz, M. ;
Young, L. T. ;
Lam, R. W. ;
Wong, H. .
MOLECULAR PSYCHIATRY, 2016, 21 (08) :1050-1056
12